{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:45:19Z","timestamp":1792572319318,"version":"4.5.0"},"reference-count":47,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"High-level Construction Dengfeng Project","award":["202513068"],"award-info":[{"award-number":["202513068"]}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1-037"],"award-info":[{"award-number":["2021-I2M-1-037"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Emerging Microbes &amp; Infections"],"DOI":"10.1080\/22221751.2026.2728779","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:28:51Z","timestamp":1792571331000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness of latent tuberculosis infection testing and treatment for elderly individuals with pulmonary fibrosis lesions in rural communities in China"],"prefix":"10.1080","author":[{"suffix":"PhD","given":"Lingyu","family":"Shen","sequence":"first","affiliation":[{"name":"Beijing Key Laboratory of Surveillance, Early Warning and Pathogen Research on Emerging Infectious Diseases, Beijing Center for Disease Prevention and Control","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"MSc","given":"Yuanzhi","family":"Di","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Surveillance, Early Warning and Pathogen Research on Emerging Infectious Diseases, Beijing Center for Disease Prevention and Control","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"MD","given":"Henan","family":"Xin","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P.R. China"]},{"name":"Key Laboratory of Pathogen Infection Prevention and Control (Ministry of Education), National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"MD","given":"Jiang","family":"Du","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P.R. China"]},{"name":"Key Laboratory of Pathogen Infection Prevention and Control (Ministry of Education), National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"PhD","given":"Peng","family":"Yang","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Surveillance, Early Warning and Pathogen Research on Emerging Infectious Diseases, Beijing Center for Disease Prevention and Control","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"PhD","given":"Daitao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Surveillance, Early Warning and Pathogen Research on Emerging Infectious Diseases, Beijing Center for Disease Prevention and Control","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"PhD","given":"Zhaomin","family":"Feng","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Surveillance, Early Warning and Pathogen Research on Emerging Infectious Diseases, Beijing Center for Disease Prevention and Control","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"BSc","given":"Boxuan","family":"Feng","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P.R. China"]},{"name":"Key Laboratory of Pathogen Infection Prevention and Control (Ministry of Education), National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"MSc","given":"Yijun","family":"He","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P.R. China"]},{"name":"Key Laboratory of Pathogen Infection Prevention and Control (Ministry of Education), National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"MSc","given":"Zihan","family":"Li","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P.R. China"]},{"name":"Key Laboratory of Pathogen Infection Prevention and Control (Ministry of Education), National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"BSc","given":"Yaqi","family":"Zhao","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P.R. China"]},{"name":"Key Laboratory of Pathogen Infection Prevention and Control (Ministry of Education), National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"PhD","given":"Juanjuan","family":"Huang","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P.R. China"]},{"name":"Key Laboratory of Pathogen Infection Prevention and Control (Ministry of Education), National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"MSc","given":"Jianguo","family":"Liang","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P.R. China"]},{"name":"Key Laboratory of Pathogen Infection Prevention and Control (Ministry of Education), National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"PhD","given":"Jie","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Surveillance, Early Warning and Pathogen Research on Emerging Infectious Diseases, Beijing Center for Disease Prevention and Control","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"PhD","given":"Xuefang","family":"Cao","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P.R. China"]},{"name":"Key Laboratory of Pathogen Infection Prevention and Control (Ministry of Education), National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"PhD","given":"Quanyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Surveillance, Early Warning and Pathogen Research on Emerging Infectious Diseases, Beijing Center for Disease Prevention and Control","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"PhD","given":"Lei","family":"Gao","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Systems Biology of Pathogens, National Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P.R. China"]},{"name":"Key Laboratory of Pathogen Infection Prevention and Control (Ministry of Education), National Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, P.R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"e_1_3_1_2_1","unstructured":"[1] World Health Organization. Global Tuberculosis Report 2024[S]. Geneva: World Health Organization 2024 ."},{"key":"e_1_3_1_3_1","unstructured":"[2] Hartman-Adams H Clark K Juckett G. Update on latent tuberculosis infection. Am Fam Physician. 2014. 89(11): 889-96."},{"key":"e_1_3_1_4_1","doi-asserted-by":"crossref","unstructured":"[3] Uplekar M Weil D Lonnroth K et al. WHO's new end TB strategy. Lancet. 2015. 385(9979): 1799-1801.","DOI":"10.1016\/S0140-6736(15)60570-0"},{"key":"e_1_3_1_5_1","doi-asserted-by":"crossref","unstructured":"[4] Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA) September 1999 and the sections of this statement. Am J Respir Crit Care Med. 2000. 161(4 Pt 2): S221-47.","DOI":"10.1164\/ajrccm.161.4.16141"},{"key":"e_1_3_1_6_1","doi-asserted-by":"crossref","unstructured":"[5] Zenner D Beer N Harris RJ Lipman MC Stagg HR van der Werf MJ. Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis. Ann Intern Med. 2017. 167(4): 248-255.","DOI":"10.7326\/M17-0609"},{"key":"e_1_3_1_7_1","unstructured":"[6] World Health Organization. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment 2020.Geneva: World Health Organization; 2020 ."},{"key":"e_1_3_1_8_1","unstructured":"[7] World Health Organization. Appendix to the Guidelines on the management of latent tuberculosis infection. Geneva:World Health Organization; 2015."},{"key":"e_1_3_1_9_1","doi-asserted-by":"crossref","unstructured":"[8] Sterling TR Njie G Zenner D et al. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC 2020. MMWR Recomm Rep. 2020. 69(1): 1-11.","DOI":"10.15585\/mmwr.rr6901a1"},{"key":"e_1_3_1_10_1","unstructured":"[9] Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. 2018. Geneva."},{"key":"e_1_3_1_11_1","unstructured":"[10] Liu YQ TDH An YS ZLX. Tuberculosis control in college students in Beijing: preventive therapy for tuberculosis-infected persons. Chin J Antitubercul. 2005. 27: 139\u2013142."},{"key":"e_1_3_1_12_1","unstructured":"[11] Gao L Li X Liu J et al. Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based multicentre prospective cohort study. Lancet Infect Dis. 2017. 17(10): 1053-1061."},{"key":"e_1_3_1_13_1","doi-asserted-by":"crossref","unstructured":"[12] Gao L Zhang H Xin H et al. Short-course regimens of rifapentine plus isoniazid to treat latent tuberculosis infection in older Chinese patients: a randomised controlled study. Eur Respir J. 2018. 52(6): 1801470 [pii].","DOI":"10.1183\/13993003.01470-2018"},{"key":"e_1_3_1_14_1","doi-asserted-by":"crossref","unstructured":"[13] Xin H Cao X Zhang H et al. Protective efficacy of 6-week regimen for latent tuberculosis infection treatment in rural China: 5-year follow-up of a randomised controlled trial. Eur Respir J. 2022. 60(1): 2102359.","DOI":"10.1183\/13993003.02359-2021"},{"key":"e_1_3_1_15_1","doi-asserted-by":"crossref","unstructured":"[14] Shen L Zhang Y Xin H et al. Association of inactive pulmonary tuberculosis lesions with the risk of active disease development in the elderly: a population-based retrospective study. ERJ Open Res. 2025;11(4):01231-02024 [pii].","DOI":"10.1183\/23120541.01231-2024"},{"key":"e_1_3_1_16_1","unstructured":"[15] Public Health Agency of Canada. Canadian Tuberculosis Standards 7th edition. Ottawa ON: Public Health Agency of Canada 2014 ."},{"key":"e_1_3_1_17_1","unstructured":"[16] Oxlade O Schwartzman K Menzies D. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis. 2007;11(1):16-26."},{"key":"e_1_3_1_18_1","doi-asserted-by":"crossref","unstructured":"[17] Porco TC Lewis B Marseille E Grinsdale J Flood JM Royce SE. Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants. BMC Public Health. 2006;6:157.","DOI":"10.1186\/1471-2458-6-157"},{"key":"e_1_3_1_19_1","doi-asserted-by":"crossref","unstructured":"[18] Wen Z Li T Zhu W Chen W Zhang H Wang W. Effect of different interventions for latent tuberculosis infections in China: a model-based study. BMC Infect Dis. 2022;22(1):488.","DOI":"10.1186\/s12879-022-07465-5"},{"key":"e_1_3_1_20_1","doi-asserted-by":"crossref","unstructured":"[19] Jiang H Li R Zhang T et al. Cost-effectiveness of preventive treatment regimens for latent tuberculosis infection among key community-level populations. BMC Med. 2025;23(1):593.","DOI":"10.1186\/s12916-025-04413-3"},{"key":"e_1_3_1_21_1","doi-asserted-by":"crossref","unstructured":"[20] Gao L Bai L Liu J et al. Annual risk of tuberculosis infection in rural China: a population-based prospective study. Eur Respir J. 2016;48(1):168-178.","DOI":"10.1183\/13993003.00235-2016"},{"key":"e_1_3_1_22_1","doi-asserted-by":"crossref","unstructured":"[21] Gao L Lu W Bai L et al. Latent tuberculosis infection in rural China: baseline results of a population-based multicentre prospective cohort study. Lancet Infect Dis. 2015;15(3):310-319.","DOI":"10.1016\/S1473-3099(14)71085-0"},{"key":"e_1_3_1_23_1","doi-asserted-by":"crossref","unstructured":"[22] Xin H Zhang H Liu J et al. Mycobacterium Tuberculosis infection among the elderly in 20 486 rural residents aged 50-70 years in Zhongmu County China. Clin Microbiol Infect. 2019;25(9):1120-1126.","DOI":"10.1016\/j.cmi.2019.01.021"},{"key":"e_1_3_1_24_1","doi-asserted-by":"crossref","unstructured":"[23] Diel R Loddenkemper R Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest. 2010. 137(4): 952-68.","DOI":"10.1378\/chest.09-2350"},{"key":"e_1_3_1_25_1","doi-asserted-by":"crossref","unstructured":"[24] Oh CE Ortiz-Brizuela E Bastos ML Menzies D. Comparing the Diagnostic Performance of QuantiFERON-TB Gold Plus to Other Tests of Latent Tuberculosis Infection: A Systematic Review and Meta-analysis. Clin Infect Dis. 2021. 73(5): e1116-e1125.","DOI":"10.1093\/cid\/ciaa1822"},{"key":"e_1_3_1_26_1","doi-asserted-by":"crossref","unstructured":"[25] Chien JY Chiang HT Lu MC et al. QuantiFERON-TB Gold Plus Is a More Sensitive Screening Tool than QuantiFERON-TB Gold In-Tube for Latent Tuberculosis Infection among Older Adults in Long-Term Care Facilities. J Clin Microbiol. 2018. 56(8): e00427-18.","DOI":"10.1128\/JCM.00427-18"},{"key":"e_1_3_1_27_1","unstructured":"[26] World Health Organization. WHO operationalhandbook on tuberculosis.Module 1: Prevention Tuberculosis preventive treatment. Geneva: World Health Organization; 2024 ."},{"key":"e_1_3_1_28_1","doi-asserted-by":"crossref","unstructured":"[27] Zhang H Xin H Du Y et al. Tuberculosis preventive treatment among individuals with inactive tuberculosis suggested by untreated radiographic abnormalities: a community-based randomized controlled trial. Emerg Microbes Infect. 2023. 12(1): e2169195.","DOI":"10.1080\/22221751.2023.2169195"},{"key":"e_1_3_1_29_1","doi-asserted-by":"crossref","unstructured":"[28] Li J Munsiff SS Tarantino T Dorsinville M. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Int J Infect Dis. 2010. 14(4): e292-7.","DOI":"10.1016\/j.ijid.2009.05.007"},{"key":"e_1_3_1_30_1","unstructured":"[29] Menzies D Al Jahdali H Al Otaibi B. Recent developments in treatment of latent tuberculosis infection. Indian J Med Res. 2011. 133(3): 257-66."},{"key":"e_1_3_1_31_1","doi-asserted-by":"crossref","unstructured":"[30] Cao X Guo T Xin H et al. Cost-effectiveness of latent tuberculosis infection testing and treatment with 6-week regimen among key population in rural communities in China: a decision analysis study. Eur J Clin Microbiol Infect Dis. 2024;43(5):809-820.","DOI":"10.1007\/s10096-024-04777-z"},{"key":"e_1_3_1_32_1","unstructured":"[31] Wang N Ma Y Liu YH et al. Risk of Treatment Failure in Patients with Drug-susceptible Pulmonary Tuberculosis in China. Biomed Environ Sci. 2016. 29(8): 612-617."},{"key":"e_1_3_1_33_1","doi-asserted-by":"crossref","unstructured":"[32] Zhang L Meng Q Chen S et al. Treatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang China 2009-2013. Clin Microbiol Infect. 2018. 24(4): 381-388.","DOI":"10.1016\/j.cmi.2017.07.008"},{"key":"e_1_3_1_34_1","doi-asserted-by":"crossref","unstructured":"[33] Ruan QL Yang QL Sun F et al. Recurrent pulmonary tuberculosis after treatment success: a population-based retrospective study in China. Clin Microbiol Infect. 2022. 28(5): 684-689.","DOI":"10.1016\/j.cmi.2021.09.022"},{"key":"e_1_3_1_35_1","doi-asserted-by":"crossref","unstructured":"[34] Liu Q Qiu B Li G et al. Tuberculosis reinfection and relapse in eastern China: a prospective study using whole-genome sequencing. Clin Microbiol Infect. 2022. 28(11): 1458-1464.","DOI":"10.1016\/j.cmi.2022.05.019"},{"key":"e_1_3_1_36_1","doi-asserted-by":"crossref","unstructured":"[35] Abuaku B Tan H Li X Chen M Huang X. Treatment default and death among tuberculosis patients in Hunan China. Scand J Infect Dis. 2010. 42(4): 281-7.","DOI":"10.3109\/00365540903493723"},{"key":"e_1_3_1_37_1","doi-asserted-by":"crossref","unstructured":"[36] Quaife M Houben R Allwood B et al. Post-tuberculosis mortality and morbidity: valuing the hidden epidemic. Lancet Respir Med. 2020. 8(4): 332-333.","DOI":"10.1016\/S2213-2600(20)30039-4"},{"key":"e_1_3_1_38_1","doi-asserted-by":"crossref","unstructured":"[37] Zhou G Luo S He J et al. Effectiveness and safety of tuberculosis preventive treatment for contacts of patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Clin Microbiol Infect. 2024. 30(2): 189-196.","DOI":"10.1016\/j.cmi.2023.09.015"},{"key":"e_1_3_1_39_1","unstructured":"[38] National Bureau of Statistics of the People's Republic of China. Major Results of the Seventh National Population Census[EB\/OL]. Beijing: National Bureau of Statistics of the People's Republic of China.2021. [2025-02-23]. https:\/\/www.stats.gov.cn\/tjsj\/zxfb\/202105\/t20210510_1817175.html ."},{"key":"e_1_3_1_40_1","doi-asserted-by":"crossref","unstructured":"[39] Xu CH Jeyashree K Shewade HD et al. Inequity in catastrophic costs among tuberculosis-affected households in China. Infect Dis Poverty. 2019. 8(1): 46.","DOI":"10.1186\/s40249-019-0564-2"},{"key":"e_1_3_1_41_1","unstructured":"[40] World Health Organization. The WHO manual of diagnostic imaging Radiographic Anatomy and Interpretation of the chest and the pulmonary System.Geneva: World Health Organization; 2012 ."},{"key":"e_1_3_1_42_1","unstructured":"[41] World Health Organization. Chest radiography in tuberculosis detection: summary of current WHO recommendations and guidance on programmatic approaches[S]. Geneva: World Health Organization 2016 ."},{"key":"e_1_3_1_43_1","doi-asserted-by":"crossref","unstructured":"[42] Sadatsafavi M Marra C Marra F Moran O FitzGerald JM Lynd L. A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework. Value Health. 2013. 16(1): 66-75.","DOI":"10.1016\/j.jval.2012.09.006"},{"key":"e_1_3_1_44_1","doi-asserted-by":"crossref","unstructured":"[43] Kittikraisak W Kingkaew P Teerawattananon Y et al. Health related quality of life among patients with tuberculosis and HIV in Thailand. PLoS One. 2012. 7(1): e29775.","DOI":"10.1371\/journal.pone.0029775"},{"key":"e_1_3_1_45_1","doi-asserted-by":"crossref","unstructured":"[44] Holland DP Sanders GD Hamilton CD Stout JE. Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection. Am J Respir Crit Care Med. 2009. 179(11): 1055-60.","DOI":"10.1164\/rccm.200901-0153OC"},{"key":"e_1_3_1_46_1","unstructured":"[45] Organization WH. Guidelines on the Management of Latent Tuberculosis Infection. 2015. Geneva: World Health Organization; 2015."},{"key":"e_1_3_1_47_1","doi-asserted-by":"crossref","unstructured":"[46] Johnson KT Churchyard GJ Sohn H Dowdy DW. Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden Settings. Clin Infect Dis. 2018. 67(7): 1072-1078.","DOI":"10.1093\/cid\/ciy230"},{"key":"e_1_3_1_48_1","doi-asserted-by":"crossref","unstructured":"[47] Tasillo A Salomon JA Trikalinos TA Horsburgh CR Jr Marks SM Linas BP. Cost-effectiveness of Testing and Treatment for Latent Tuberculosis Infection in Residents Born Outside the United States With and Without Medical Comorbidities in a Simulation Model. JAMA Intern Med. 2017;177(12):1755-1764.","DOI":"10.1001\/jamainternmed.2017.3941"}],"container-title":["Emerging Microbes &amp; Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/22221751.2026.2728779","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/22221751.2026.2728779","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/22221751.2026.2728779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:29:02Z","timestamp":1792571342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/22221751.2026.2728779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":47,"alternative-id":["10.1080\/22221751.2026.2728779"],"URL":"https:\/\/doi.org\/10.1080\/22221751.2026.2728779","relation":{},"ISSN":["2222-1751"],"issn-type":[{"value":"2222-1751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=temi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=temi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-10-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2728779"}}